Trepibutone

曲匹布通

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrepibutone
Drug Alias Name三乙丁酮trepibutonatrepibutonum三乙氧苯酰丙酸Supacal +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCholecystitisCholelithiasisCholangitis +[4] 
Global Approved IndicationsCholecystitisCholelithiasisCholangitis +[4] 
Approved Indications in ChinaCholecystitisBiliary Tract Diseases
Original Approved Country/TerritoryJapan
Original Approved Date1982/02/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesOhara Pharmaceutical Co LtdQian Jin Xiangjiang Pharmageuical Co Led Hunan
Inactive CompaniesN/A
Active IndicationsCholecystitisCholelithiasisCholangitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA03AX09
Related LinksWikipediaKEGG